ExLibris header image
SFX Logo
Title: Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer
Source:

Gene Therapy [0969-7128] Castelo Branco, P yr:2010


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Chang, G. "Enhanced Oncolytic Activity of Vesicular Stomatitis Virus Encoding SV5-F Protein Against Prostate Cancer." The Journal of urology 183.4 (2010): 1611-1618. Link to SFX for this item
2. Fares, F. "The potential efficacy of 3,3 '-diindolylmethane in prevention of prostate cancer development." European journal of cancer prevention 19.3 (2010): 199-203. Link to SFX for this item
3. Werden, Steven J. "Pharmacological manipulation of the Akt signaling pathway regulates myxoma virus replication and tropism in human cancer cells." Journal of virology 84.7 (2010): 3287-3302. Link to Full Text for this item Link to SFX for this item
4. Lamontagne, J. "Hepatitis B and Hepatitis C Virus Replication Upregulates Serine Protease Inhibitor Kazal, Resulting in Cellular Resistance to Serine Protease-Dependent Apoptosis." Journal of virology 84.2 (2010): 907-917. Link to Full Text for this item Link to SFX for this item
5. Rizzi, F. "Clusterin (CLU) and prostate cancer." Adv Cancer Res 105 (2009): 1-19. Link to SFX for this item
6. Bertilaccio, M. "Vasculature targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer." The Prostate 68.10 (2008): 1105-1115. Link to Full Text for this item Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced